Christina is an advisor to early- and late-stage healthcare companies on go-to-market strategy, storytelling, and fundraising, and shares her insights via Second Opinion. Learn more at www.chrissyfarr.com
Guest author Halle Tecco’s breakdown of how the companies valued at more than $1b at the peak are faring — TLDR, the results surprised her!
